Xenogeneic HER2/Neu DNA immunization
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xenogeneic HER2/Neu DNA immunization, covering 2025-06-05 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity [Phase 1]